Accession Number: | 0001209191-21-062263 |
Date: | 2021-10-28 |
Issuer: | CRINETICS PHARMACEUTICALS, INC. (CRNX) |
Original Submission Date: |
MADAN AJAY
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO, CA 92121
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-10-28 | M | 106,383 | a | $0.73 | 184,671 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.73 | 2021-10-28 | deemed execution date | M | 106,383 (d) | 2028-03-16 | common stock 106,383 | $0.73 | 0 | direct |
ID | footnote |
---|---|
f1 | includes 772 shares acquired under the issuer's employee stock purchase plan since the last section 16 filing by the reporting person. |
f2 | 25% of the shares subject to the option vested on july 17, 2017 and 1/48th of the total remaining number of shares subject to the option vest monthly thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date. |